Stanate

Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Endpoints
Mon, 08/7/17 - 11:25 am
Mallinckrodt
infantile jaundice
InfaCare
M&A
Stanate